Literature DB >> 9523090

Matrix metalloproteinases and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous.

J J Plantner1, A Smine, T A Quinn.   

Abstract

PURPOSE: We wished to establish which matrix metalloproteinases (MMPs) and metalloproteinase inhibitors (TIMPs) were present in human interphotoreceptor matrix (IPM) and vitreous.
METHODS: IPM and vitreous were obtained from postmortem human eyebank eyes. Western immunoblots were probed with antibodies against human MMPs and TIMPs. Assays specific for elastase activity were also performed.
RESULTS: Immunoblot analysis indicated the presence of MMP-1 (interstitial collagenase), MMP-2 and MMP-9 (gelatinases A and B), MMP-3 (stromelysin-1) and TIMP-1, -2 and -3 in both IPM and vitreous. MMP-7 (matrilysin) and MMP-12 (metalloelastase) were not found in either IPM or vitreous.
CONCLUSIONS: This is the first demonstration of the MMPs and TIMPs in human IPM and of the TIMPs in human vitreous. While these enzymes are most likely involved in normal turnover within the extracellular matrices that surround the neural retina, they may also play a role in a number of retinal diseases, particularly proliferative diabetic retinopathy and age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523090     DOI: 10.1076/ceyr.17.2.132.5610

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  23 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling.

Authors:  J L Ashworth; G Murphy; M J Rock; M J Sherratt; S D Shapiro; C A Shuttleworth; C M Kielty
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Fibrillin and the eye.

Authors:  J L Ashworth; C M Kielty; D McLeod
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

4.  The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU).

Authors:  G R Wallace; R A Whiston; M R Stanford; G M Wells; A J Gearing; J M Clements
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

5.  Scar remodeling after strabismus surgery.

Authors:  I H Ludwig
Journal:  Trans Am Ophthalmol Soc       Date:  1999

6.  Preservation of the structure of enzymatically-degraded bovine vitreous using synthetic proteoglycan mimics.

Authors:  Qianru Zhang; Benjamen A Filas; Robyn Roth; John Heuser; Nan Ma; Shaili Sharma; Alyssa Panitch; David C Beebe; Ying-Bo Shui
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-23       Impact factor: 4.799

Review 7.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

8.  Retinal pigment epithelial cells promote spatial reorganization and differentiation of retina photoreceptors.

Authors:  Olga L German; Edgardo Buzzi; Nora P Rotstein; Enrique Rodríguez-Boulan; Luis E Politi
Journal:  J Neurosci Res       Date:  2008-12       Impact factor: 4.164

9.  Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.

Authors:  Martin Hermel; Jonathan Prenner; Motaz Alabdulrazzak; Wendy Dailey; Michael Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

10.  Cyclic nucleotide-gated channel subunit glycosylation regulates matrix metalloproteinase-dependent changes in channel gating.

Authors:  Starla E Meighan; Peter C Meighan; Elizabeth D Rich; R Lane Brown; Michael D Varnum
Journal:  Biochemistry       Date:  2013-11-11       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.